Aagami has been appointed for BD support, by an independent global Contract Research Organization (CRO) offering comprehensive non clinical GLP research services for regulatory submissions, worldwide.

Spread across 4 locations worldwide (India, UK, USA and Japan), the client has 350 employees serving 400+ clients across 80+ countries with over 27,000 GLP Studies completed and well received By the Global Regulators (Most of them aimed At Multi-regulator filing including US FDA, and EMA).

Best in class quality, timely delivery and cost advantages are 3 key characteristics of the client.

Aagami will leverage its existing network with Lifescience companies and global deal experience, apart from presence in US, to contribute to the success of its client.